EUVIMEDDescoperă EUVIMED
Open access · CC BY 4.0

Aspectos morfogenéticos da anemia megaloblástica: implicações e terapêuticas na prática farmacológica.

Glasse Hellin Chaves Costa, Gustavo Pereira Calado

Revista ft · 2026-06-09 · 30 (159) · 01-13

DOI: 10.69849/brpgzh54 ↗

At a glance

Journal article in Revista ft, published online on 2026-06-09. Written by Glasse Hellin Chaves Costa and 1 co-authors. The full text is freely available (open access, CC BY 4.0).

RezumatDate bibliograficeCiteRelated studies

Abstract (original language)

Megaloblastic anemia is a relevant hematological disorder characterized by morphological and biochemical alterations resulting from vitamin B12 and/or folate deficiency. This study aims to review, through a bibliographic approach, the physiological, biochemical, and morphogenetic aspects related to the disease, emphasizing its pathophysiological mechanisms, laboratory markers, and therapeutic implications. Initially, the physiology of hematopoiesis and the metabolism of the vitamins involved in DNA synthesis are presented, highlighting the interdependence between cobalamin and folate in the methylation cycle. Subsequently, the pathological mechanisms of megaloblastic anemia are discussed, which result in ineffective erythropoiesis, the presence of macrocytes and megaloblasts, in addition to neurological repercussions specific to vitamin B12 deficiency. Morphological alterations in peripheral blood and bone marrow, such as hypersegmented neutrophils and nuclear-cytoplasmic asynchrony, are described as classical diagnostic markers. The section referring to biomarkers highlights the importance of serum vitamin B12, folate, homocysteine, and methylmalonic acid measurements, as well as hemolysis parameters such as LDH and bilirubin. Challenges in differential diagnosis with other causes of macrocytosis are also addressed, in addition to laboratory recommendations based on recent consensus. It is concluded that the integration of clinical, hematological, and biochemical findings is essential for accurate diagnosis, prevention of irreversible complications, and definition of appropriate pharmacological approaches, reinforcing the relevance of the topic in clinical and laboratory practice.

Cite

APA

Costa, G. H. C., & Calado, G. P. (2026). Aspectos morfogenéticos da anemia megaloblástica: implicações e terapêuticas na prática farmacológica. Revista ft, 30(159), 01-13. https://doi.org/10.69849/brpgzh54

Vancouver

Costa GHC, Calado GP. Aspectos morfogenéticos da anemia megaloblástica: implicações e terapêuticas na prática farmacológica. Revista ft. 2026;30(159):01-13. doi:10.69849/brpgzh54

BibTeX
@article{Costa2026,
  author = {Costa, Glasse Hellin Chaves and Calado, Gustavo Pereira},
  title = {Aspectos morfogenéticos da anemia megaloblástica: implicações e terapêuticas na prática farmacológica},
  journal = {Revista ft},
  year = {2026},
  volume = {30},
  number = {159},
  pages = {01--13},
  doi = {10.69849/brpgzh54}
}
Start for free →